Literature DB >> 20654073

[Survey on the hospitalization treatment status of acute myocardial infarction patients in 13 hospitals of western medicine and traditional Chinese medicine in Beijing].

Hong-xu Liu1, Wei Gao, Dong Zhao, Ju-ju Shang.   

Abstract

OBJECTIVE: To survey the treatment status and clinical features of hospitalized patients with acute myocardial infarction (AMI) of 13 hospitals in Beijing in 2005.
METHODS: Uniform questionnaires were used to register AMI patients hospitalized from January 1 to December 31, 2005 in the 13 hospitals including traditional Chinese medicine (TCM) hospitals (n = 6) and western medicine hospitals (WM, n = 7) from Beijing. A total of 1663 AMI patients were registered (1366 cases in WM hospitals and 297 cases in TCM hospitals). An Access database was established and patient information was input, the clinical features and treatment status of hospitalized AMI patients were analyzed.
RESULTS: The mean age was (63.9 +/- 12.8) years old [(62.8 +/- 12.8) years for WM Hospitals and (69.1 +/- 11.8) years for TCM hospitals, P < 0.05], male to female ratio was 2.4:1 (2.7:1 for WM hospitals and 1.6:1 for TCM hospitals, P < 0.05). The median time to hospital was 14 hours in TCM hospitals and 11 hours in WM hospitals (P > 0.05). Incidences of history of cerebrovascular disease, high blood pressure, diabetes, hyperlipidemia and complications such as in-patient arrhythmia, cardiac insufficiency, cardiogenic shock were significantly higher in TCM hospitals than in WM hospitals. The total mortality of 1663 AMI cases was 8.2% (15.8% in TCM hospitals vs. 6.6% in WM hospitals, P < 0.01). The reperfusion rate including emergency PCI and thrombolytic therapy rate was 31.3% in 13 hospitals (33.3% in WM hospitals vs. 21.9% in TCM hospitals, P < 0.05). Percent of guideline recommend drug use for AMI was as follows: aspirin 93.6%, ACEI and ARB 85.1%, beta-blocker 78.7%, low molecular weight heparin 85.4%, statins 74.7%.
CONCLUSIONS: Reperfusion therapy and guideline recommended drugs were widely used although there was a need for further improvement. The hospitalized mortality showed a downward trend compared with results from five years ago, patients in TCM hospitals had an independent clinical features.

Entities:  

Mesh:

Year:  2010        PMID: 20654073

Source DB:  PubMed          Journal:  Zhonghua Xin Xue Guan Bing Za Zhi        ISSN: 0253-3758


  5 in total

1.  Clinical pathways based on integrative medicine in chinese hospitals improve treatment outcomes for patients with acute myocardial infarction: a multicentre, nonrandomized historically controlled trial.

Authors:  Lei Wang; Minzhou Zhang; Liheng Guo; Jianyong Qi; Haiming Luo; Hankang He; Xiaolong Wang; Haiyu Yang; Yang Wu; Canming Miu; Xiaohu Chen; Jiashin Wu
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-13       Impact factor: 2.629

2.  Trends in the use of guideline-recommended medications and in-hospital mortality of patients with acute myocardial infarction in a Chinese population.

Authors:  Jing Hu; Yanming Xie; Zheng Shu; Wei Yang; Siyan Zhan
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

3.  Impact of organizational and individual factors on patient-provider relationships: A national survey of doctors, nurses and patients in China.

Authors:  Ping Zhang; Fang Wang; Yao Cheng; Liu Yi Zhang; Bei Zhu Ye; Hong Wei Jiang; Yi Sun; Xi Zhu; Yuan Liang
Journal:  PLoS One       Date:  2017-07-28       Impact factor: 3.240

4.  Recent Trends in Hospitalization for Acute Myocardial Infarction in Beijing: Increasing Overall Burden and a Transition From ST-Segment Elevation to Non-ST-Segment Elevation Myocardial Infarction in a Population-Based Study.

Authors:  Qian Zhang; Dong Zhao; Wuxiang Xie; Xueqin Xie; Moning Guo; Miao Wang; Wei Wang; Wanru Liu; Jing Liu
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

5.  Association Between Medication Adherence and 1-Year Major Cardiovascular Adverse Events After Acute Myocardial Infarction in China.

Authors:  Pu Shang; Gordon G Liu; Xin Zheng; P Michael Ho; Shuang Hu; Jing Li; Zihan Jiang; Xi Li; Xueke Bai; Yan Gao; Chao Xing; Yun Wang; Sharon-Lise Normand; Harlan M Krumholz
Journal:  J Am Heart Assoc       Date:  2019-05-07       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.